Project Resonance · USPTO Provisional 63/983,663
A wearable that trains you off itself.
iResonate measures coherence across your neural, cardiac, and respiratory systems in real time. When that coherence rises, its own stimulation fades. We are not trying to make you dependent on this device — we are trying to make a device that eventually sits in a drawer while the state remains.
Modalities / 5
Sensing / EEG · ECG · Resp · GSR
Data / on-device only
Status / MVE validated
We're not building God. We're building a better antenna.
— Project thesis, v1.0
01 / Mechanism
Five stimulation modes. One composite target.
The device combines four entraining modalities plus a sham condition for blinded self-experimentation. Stimulation is phase-locked to your individual alpha frequency, measured on the first session and re-measured each time you put the device on.
Mode A
Acoustic entrainment
Bone conduction · IAF-locked
Binaural and isochronic tones delivered through bone conduction transducers, tracking your individual alpha frequency (8–13 Hz) measured in-session.
Mode B
Photobiomodulation
850 nm NIR · pulsed 10 Hz
Near-infrared light pulsed transcranially at 10 Hz. Well-established wavelength for cortical tissue penetration; dosing held within published safe ranges.
Mode C
Gamma flicker
Visible LED · 40 Hz
40 Hz visible-spectrum pulsing, shown in published literature to entrain gamma-band cortical activity. Hardware lockout physically prevents the 15–25 Hz photosensitive seizure range.
Mode D
Phase-locked composite
All three · coherent phase
All three modalities running simultaneously with phase coherence across channels. The unique signature of this device: not parallel stimulation, but synchronized stimulation.
Mode E
Sham condition
Appears active · no signal
Device shows all status indicators and haptic feedback but emits no entraining signal. Built in, not added later. For users, researchers, and reviewers who want to test for placebo independently.
Composite Coherence Index · computed on-device at 10 Hz
CCI = Neural × 0.40 + Cardiac × 0.30 + Respiratory × 0.15 + Cross-system × 0.15
Phase 1
0–30
Acquisition
Full-intensity multi-modal driving at your individual alpha frequency.
Phase 2
30–55
Transition
Frequency sweep toward 7.83 Hz Schumann. Theta-gamma coupling introduced.
Phase 3
55–75
Deepening
Lock at Schumann. Intensity reduced 30%. Coupling optimization.
Phase 4
75–100
Sustain
Near-silent. Monitoring only. Re-engages if coherence drops more than 10 points in 10 seconds.
02 / Posture
Progressive withdrawal, by design.
Every consumer neurostimulation device on the market has the same incentive: keep you using it. We have deliberately built the opposite. As your coherence rises, stimulation automatically reduces. Every fifth session runs two minutes of sensors-only baseline, with no output at all, so your unassisted state is measurable.
What iResonate does
- Measures four coherence signals simultaneously
- Reduces its own output as those signals rise
- Tracks time-to-sustain across sessions
- Keeps all data encrypted and on-device
- Ships with a sham mode built into firmware
- Ships with hardware-level seizure lockout
What it explicitly does not do
- Diagnose, treat, cure, or prevent any condition
- Send any biometric data off the device
- Require an account, login, or cloud sync
- Push notifications outside of active sessions
- Increase engagement as a product goal
- Market to anyone under the age of 18
03 / Architecture
Three tiers. Validation first.
The device exists in three hardware generations, intentionally staged. The minimum viable experiment is already on the bench. Every subsequent step is gated by what that rig produces.
| Generation |
Purpose |
BOM |
| MVE · Breadboard |
Dual-node ESP32-S3 rig for single- vs multi-modality comparison |
~$125–235 |
| V1 · Full prototype |
Three-unit wearable (headband, chest strap, controller) with SD logging |
~$463 |
| V2 · Consumer |
Single 48g titanium band. Circumferential flex PCB. Collapsed sensor stack. |
~$162 |
| Safety layer |
Implementation |
Enforcement |
| Photosensitive lockout |
Physical blocker of 15–25 Hz flicker range |
hardware |
| Independent safety MCU |
ATtiny816 · one-time-programmable · no OTA path |
hardware |
| Kill switch authority |
MOSFET on all output lines, controlled only by safety MCU |
hardware |
| Secure boot |
ESP32-S3 v2 · signed OTA only · eFuse-disabled JTAG |
firmware |
| Data sovereignty |
Zero cloud · zero telemetry · no account required |
architecture |
04 / Origin
Why this device.
This project did not start as a product. It started as a personal problem. Eighteen years of compensation patterns after a cervical spine injury had left a corrupted proprioceptive baseline — a nervous system that had learned to lie to itself about where the body was in space. After the 2025 ACDF fusion at C4–C6, the question stopped being "how do I sit straight" and became "how do you measure a signal you can no longer feel."
The answer, it turned out, was not a better posture cue. It was a better way to watch your whole system phase-lock, across scales, in real time — and then step out of the way once it did. That insight became two devices, on two different tracks. AIDLAS watches the body's mechanics. iResonate watches its rhythms.
This device is the one we would want to have had, for anyone who has ever felt their internal signals go quiet.
05 / Intellectual property
Filed, before built.
The full system is disclosed in a USPTO provisional, filed as micro entity, covering the composite coherence index, the progressive withdrawal protocol, the independent safety MCU architecture, the cross-system phase-locking as a control signal, and the environmental detection array.
RESONANCE-001
Systems and methods for wearable neurostimulation and physiological coherence optimization
Five novel claim families distinguishing this system from known prior art in the EEG-wearable, photobiomodulation, and closed-loop neurofeedback categories. Non-provisional conversion window closes February 2027.
Application
63/983,663
Filed
Feb 15, 2026
Entity
Micro
Office
USPTO
Is this a medical device?
+
No. iResonate is a wellness wearable and is not cleared, certified, or registered as a medical device by the FDA or any other regulatory body. It does not diagnose, treat, cure, or prevent any condition. Intended for healthy adults aged 18 and older. Not suitable for individuals with a history of seizure disorder, photosensitive epilepsy, cardiac arrhythmia, implanted electronic medical devices, active neurological or psychiatric treatment, or during pregnancy — please consult a physician first.
How is this different from other wearables in this space?
+
Existing consumer devices typically measure one signal or deliver one modality. None compute a composite coherence metric across four systems. None reduce their own output as user-generated coherence rises. None ship with an independent, one-time-programmable safety MCU architecture. The prior-art analysis distinguishing each of these elements is disclosed in the provisional filing.
Why should I trust the sham mode actually works?
+
Because it was not added as a marketing feature — it is a first-class firmware state, visible in the open specification and verifiable at the hardware level. The purpose of including it is to let users and researchers measure placebo effect against active modes in their own sessions. The device does not tell you when sham is running until the session is complete.
What data leaves the device?
+
None. There is no account, no cloud, no telemetry, no companion app that phones home. Session data is stored in encrypted flash on the device and can be exported over a physically-enabled USB connection at the user's choice. Charging contacts are power-only, with no data lines.
Can I read the actual research?
+
The foundational mechanisms — photobiomodulation at 800–850 nm, gamma flicker entrainment, HRV resonant frequency at ~0.1 Hz, and the 7.83 Hz Schumann reference — are all well-cited in published literature. What iResonate contributes is the composite metric and the withdrawal protocol. That contribution is fully disclosed in the provisional and will be validated through pilot protocols and published results as they become available.
06 / Waitlist
If the thesis lands for you, tell us who you are.
No launch date. No price commitment. No marketing emails. You will hear from us only when we have something worth telling you — a pilot opening, a validation result, a price we can stand behind.
We respond personally · No list · No automation